Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Ionis Pharmaceuticals Inc.
DescriptionLigand conjugated antisense version of an oligonucleotide that inhibits apolipoprotein A
Molecular Target
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: Antisense
Latest Stage of DevelopmentPhase II
Standard IndicationHyperlipidemia
Indication DetailsTreat hyperlipidemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today